We have been active in the synthesis and characterization of tin-based antitumour compounds for several years and we would like to summarize here the results that have already been patented (1) and that may therefore be disclosed(2). We synthesized some diorganotin 2,6-pyridinedicarboxylates.The dimethyltin compound has been found inactive in vitro, whereas the di-n-butyltin, di-t-butyltin and diphenyltin compounds were found more active than cisplatin(2).
hope that have convinced you that several organotin compounds exhibit rather promising in vitro antitumour activities again human tumour cell lines. Of course we have to wait for the in vivo test results before claiming anything about the interest of such compounds for cancer chemotherapy.
More work has to be done in the field of the preparation and testing of organotin molecules that might become useful antitumour drugs in the future.
